These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33336635)

  • 21. The use of the Montreal Cognitive Assessment (MoCA) screening tool to evaluate cognitive deficits in Lebanese in-patients with schizophrenia.
    Haddad C; Salameh P; Sacre H; Clément JP; Calvet B
    Asian J Psychiatr; 2022 Apr; 70():103029. PubMed ID: 35189473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment.
    Fujiwara Y; Suzuki H; Yasunaga M; Sugiyama M; Ijuin M; Sakuma N; Inagaki H; Iwasa H; Ura C; Yatomi N; Ishii K; Tokumaru AM; Homma A; Nasreddine Z; Shinkai S
    Geriatr Gerontol Int; 2010 Jul; 10(3):225-32. PubMed ID: 20141536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
    Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
    Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adapted MMSE and TYM cognitive tests: how much powerful in screening for Alzheimer's disease in Iranian people.
    Salami M; Alinaghipour A; Daneshvar R; Hamidi GA; Agahi A; Soheili M; Akbari H; Esmaeili Taba SM
    Aging Ment Health; 2020 Jun; 24(6):1010-1017. PubMed ID: 30884962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Paired Associates Learning (PAL) Test: 30 Years of CANTAB Translational Neuroscience from Laboratory to Bedside in Dementia Research.
    Barnett JH; Blackwell AD; Sahakian BJ; Robbins TW
    Curr Top Behav Neurosci; 2016; 28():449-74. PubMed ID: 27646012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychometric Properties of Alzheimer's Disease Assessment Scale-Cognitive Subscale for Mild Cognitive Impairment and Mild Alzheimer's Disease Patients in an Asian Context.
    Zainal NH; Silva E; Lim LL; Kandiah N
    Ann Acad Med Singap; 2016 Jul; 45(7):273-83. PubMed ID: 27523508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validity of the Georgian Montreal Cognitive Assessment for the Screening of Mild Cognitive Impairment and Dementia.
    Janelidze M; Mikeladze N; Bochorishvili N; Dzagnidze A; Kapianidze M; Mikava N; Khatiashvili I; Kakhiani D; Mirvelashvili E; Shiukashvili N; Nadareishvili Z
    Am J Alzheimers Dis Other Demen; 2017 Feb; 32(1):36-40. PubMed ID: 27909150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Montreal Cognitive Assessment and Mini-Mental State Examination performance in patients with mild-to-moderate dementia with Lewy bodies, Alzheimer's disease, and normal participants in Taiwan.
    Wang CS; Pai MC; Chen PL; Hou NT; Chien PF; Huang YC
    Int Psychogeriatr; 2013 Nov; 25(11):1839-48. PubMed ID: 23919950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing a Brief Neuropsychological Battery for Early Diagnosis of Cognitive Impairment.
    Liew TM
    J Am Med Dir Assoc; 2019 Aug; 20(8):1054.e11-1054.e20. PubMed ID: 30992186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients.
    Tiffin-Richards FE; Costa AS; Holschbach B; Frank RD; Vassiliadou A; Krüger T; Kuckuck K; Gross T; Eitner F; Floege J; Schulz JB; Reetz K
    PLoS One; 2014; 9(10):e106700. PubMed ID: 25347578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity of the Montreal Cognitive Assessment in screening for cognitive impairment in patients with newly diagnosed high-grade glioma.
    Ribeiro M; Durand T; Roussel M; Feuvret L; Jacob J; Psimaras D; Noel G; Keller A; Bompaire F; Hoang-Xuan K; Bernier MO; Godefroy O; Ricard D
    J Neurooncol; 2020 Jun; 148(2):335-342. PubMed ID: 32415644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do the Cambridge Neuropsychological Test Automated Battery episodic memory measures discriminate amnestic mild cognitive impairment?
    Juncos-Rabadán O; Pereiro AX; Facal D; Reboredo A; Lojo-Seoane C
    Int J Geriatr Psychiatry; 2014 Jun; 29(6):602-9. PubMed ID: 24150876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE.
    Raghunath S; Glikmann-Johnston Y; Morand E; Stout JC; Hoi A
    Lupus Sci Med; 2021 Dec; 8(1):. PubMed ID: 34911821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between handgrip strength and cognition in a Chinese population with Alzheimer's disease and mild cognitive impairment.
    Su H; Sun X; Li F; Guo Q
    BMC Geriatr; 2021 Aug; 21(1):459. PubMed ID: 34380435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of two Chinese versions of Montreal Cognitive Assessment for Screening of Mild Cognitive Impairment.
    Huang YY; Qian SX; Guan QB; Chen KL; Zhao QH; Lu JH; Guo QH
    Appl Neuropsychol Adult; 2021; 28(1):88-93. PubMed ID: 31014115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construct validity of the Visual Cognitive Assessment Test (VCAT)-a cross-cultural language-neutral cognitive screening tool.
    Low A; Lim L; Lim L; Wong B; Silva E; Ng KP; Kandiah N
    Int Psychogeriatr; 2020 Jan; 32(1):141-149. PubMed ID: 31111797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the Short Test of Mental Status and the Montreal Cognitive Assessment Across the Cognitive Spectrum.
    Townley RA; Syrjanen JA; Botha H; Kremers WK; Aakre JA; Fields JA; Machulda MM; Graff-Radford J; Savica R; Jones DT; Knopman DS; Petersen RC; Boeve BF
    Mayo Clin Proc; 2019 Aug; 94(8):1516-1523. PubMed ID: 31280871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.